Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The resulting costs of treatment may be a barrier to accessing healthcare products, especially in cost-conscious or emerging economies
In cell experiments, GLP-1 was found to have more mechanisms that may inhibit liver fat synthesis, such as FAM3A, NRF2, NaB, SHP1/AMPK, NLRP3, FGF21, IRS2, and other signaling pathways, which also provided direct evidence for the role of GLP-1R in the regulation of lipid metabolism in the liver
Are self-paying and want transparent pricing: The cash-pay structure means pricing is published upfront, without the insurance pre-authorization process that has been a significant obstacle for many patients seeking GLP-1 prescriptions through traditional channels
Nutritional support No nutritional support, meal plans, or dietary guidance are offered
Females predominated (n = 18,907, 65.3%) over males (n = 8,838, 30.5%)
Current Pharmaceutical Design
US$ 27.97
US$ 24.35
US$ 29.11
US$ 27.21
US$ 20.32
US$ 22.00
US$ 23.34
US$ 28.78
